
ASX vs GSK
$ASX vs $GSK head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ASX vs GSK: the quick read
- ·ASX is the larger company by market cap ($101.51B vs $94.14B).
- ·ASX has been more active on our scanner (146 vs 62 alerts in 30 days).
- ·GSK has the smaller float (2.00B vs 4.45B), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Semiconductors & Related Devices vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 146 and 62 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 8% of each other on market cap, which makes the rest of this table the interesting part.
- ·They have diverged badly over the year: ASX is near the top of its 52-week range while GSK is near the bottom of its own.
- ·Both pay a dividend, so this is one of the few pairs here where yield is a fair tiebreaker.
- ·GSK is the one in play today, trading about 2.2x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ASX and GSK on TheDesperateTrader.
- Is ASX or GSK the better stock?
- "Better" depends on your goal, and these two are not alike. ASX is the larger company by market cap ($101.51B vs $94.14B). ASX has been more active on our scanner (146 vs 62 alerts in 30 days). GSK has the smaller float (2.00B vs 4.45B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ASX and GSK?
- The differences that matter: they are not in the same business - ASX is semiconductors & related devices and GSK is pharmaceutical preparations; they are similar in size ($101.51B vs $94.14B); they trade at very different share prices ($45.50 vs $46.51); ASX sits at 93% of its 52-week range against 19% for GSK; our scanner flagged ASX 146 times in the last 30 days against 62 for GSK. Everything above is measured from the latest completed session and SEC filings.
- Which of ASX and GSK is more active right now?
- Right now ASX is at about 1.3x its normal volume and GSK is at about 2.2x, so GSK is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ASX or GSK? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ASX and GSK comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.